Visfatin is involved in TNFα-mediated insulin resistance via an NAD⁺/Sirt1/PTP1B pathway in 3T3-L1 adipocytes

References

• Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett 2008; 582:117 - 31; http://dx.doi.org/10.1016/j.febslet.2007.11.051; PMID: 18037376
   PubMed Web of Science ®Google Scholar
• Nieto-Vazquez I, Fernández-Veledo S, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008; 114:183 - 94; http://dx.doi.org/10.1080/13813450802181047; PMID: 18629684
   PubMedGoogle Scholar
• Tourniaire F, Romier-Crouzet B, Lee JH, Marcotorchino J, Gouranton E, Salles J, Malezet C, Astier J, Darmon P, Blouin E, et al. Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated by NF-κB. PLoS One 2013; 8:e66515; http://dx.doi.org/10.1371/journal.pone.0066515; PMID: 23824685
   PubMed Web of Science ®Google Scholar
• Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389:610 - 4; http://dx.doi.org/10.1038/39335; PMID: 9335502
   PubMed Web of Science ®Google Scholar
• Ruan H, Miles PD, Ladd CM, Ross K, Golub TR, Olefsky JM, Lodish HF. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes 2002; 51:3176 - 88; http://dx.doi.org/10.2337/diabetes.51.11.3176; PMID: 12401708
   PubMed Web of Science ®Google Scholar
• Pirola L, Johnston AM, Van Obberghen E. Modulation of insulin action. Diabetologia 2004; 47:170 - 84; http://dx.doi.org/10.1007/s00125-003-1313-3; PMID: 14722654
   PubMed Web of Science ®Google Scholar
• Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Rondinone CM, Valverde AM, Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 2007; 56:404 - 13; http://dx.doi.org/10.2337/db06-0989; PMID: 17259385
   PubMed Web of Science ®Google Scholar
• Koren S, Fantus IG. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2007; 21:621 - 40; http://dx.doi.org/10.1016/j.beem.2007.08.004; PMID: 18054739
   PubMed Web of Science ®Google Scholar
• Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 2008; 283:14230 - 41; http://dx.doi.org/10.1074/jbc.M800061200; PMID: 18281274
   PubMed Web of Science ®Google Scholar
• Egawa K, Maegawa H, Shimizu S, Morino K, Nishio Y, Bryer-Ash M, Cheung AT, Kolls JK, Kikkawa R, Kashiwagi A. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells. J Biol Chem 2001; 276:10207 - 11; http://dx.doi.org/10.1074/jbc.M009489200; PMID: 11136729
   PubMed Web of Science ®Google Scholar
• Venable CL, Frevert EU, Kim YB, Fischer BM, Kamatkar S, Neel BG, Kahn BB. Overexpression of protein-tyrosine phosphatase-1B in adipocytes inhibits insulin-stimulated phosphoinositide 3-kinase activity without altering glucose transport or Akt/Protein kinase B activation. J Biol Chem 2000; 275:18318 - 26; http://dx.doi.org/10.1074/jbc.M908392199; PMID: 10751417
   PubMed Web of Science ®Google Scholar
• Shimizu S, Maegawa H, Egawa K, Shi K, Bryer-Ash M, Kashiwagi A. Mechanism for differential effect of protein-tyrosine phosphatase 1B on Akt versus mitogen-activated protein kinase in 3T3-L1 adipocytes. Endocrinology 2002; 143:4563 - 9; http://dx.doi.org/10.1210/en.2002-220517; PMID: 12446583
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999; 283:1544 - 8; http://dx.doi.org/10.1126/science.283.5407.1544; PMID: 10066179
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000; 20:5479 - 89; http://dx.doi.org/10.1128/MCB.20.15.5479-5489.2000; PMID: 10891488
   PubMed Web of Science ®Google Scholar
• Owen C, Czopek A, Agouni A, Grant L, Judson R, Lees EK, Mcilroy GD, Göransson O, Welch A, Bence KK, et al. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. PLoS One 2012; 7:e32700; http://dx.doi.org/10.1371/journal.pone.0032700; PMID: 22389718
   PubMed Web of Science ®Google Scholar
• Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007; 6:307 - 19; http://dx.doi.org/10.1016/j.cmet.2007.08.014; PMID: 17908559
   PubMed Web of Science ®Google Scholar
• Feige JN, Auwerx J. Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol 2008; 20:303 - 9; http://dx.doi.org/10.1016/j.ceb.2008.03.012; PMID: 18468877
   PubMed Web of Science ®Google Scholar
• Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004; 73:417 - 35; http://dx.doi.org/10.1146/annurev.biochem.73.011303.073651; PMID: 15189148
   PubMed Web of Science ®Google Scholar
• Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403:795 - 800; http://dx.doi.org/10.1038/35001622; PMID: 10693811
   PubMed Web of Science ®Google Scholar
• Imai S, Kiess W. Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes. Front Biosci (Landmark Ed) 2009; 14:2983 - 95; http://dx.doi.org/10.2741/3428; PMID: 19273250
   PubMed Web of Science ®Google Scholar
• Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444:337 - 42; http://dx.doi.org/10.1038/nature05354; PMID: 17086191
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127:1109 - 22; http://dx.doi.org/10.1016/j.cell.2006.11.013; PMID: 17112576
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, Lu JC, Smith JJ, Jirousek MR, Olefsky JM. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol 2009; 29:1363 - 74; http://dx.doi.org/10.1128/MCB.00705-08; PMID: 19103747
   PubMed Web of Science ®Google Scholar
• Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Zhao SX, Zhao JM, Yu J. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scand J Gastroenterol 2009; 44:1121 - 31; http://dx.doi.org/10.1080/00365520903114912; PMID: 19606393
   PubMed Web of Science ®Google Scholar
• van der Horst A, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem 2004; 279:28873 - 9; http://dx.doi.org/10.1074/jbc.M401138200; PMID: 15126506
   PubMed Web of Science ®Google Scholar
• Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 2004; 279:50754 - 63; http://dx.doi.org/10.1074/jbc.M408388200; PMID: 15381699
   PubMed Web of Science ®Google Scholar
• Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007; 23:164 - 70; http://dx.doi.org/10.1097/MOG.0b013e32801b3c8f; PMID: 17268245
   PubMed Web of Science ®Google Scholar
• Dahl TB, Holm S, Aukrust P, Halvorsen B. Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu Rev Nutr 2012; 32:229 - 43; http://dx.doi.org/10.1146/annurev-nutr-071811-150746; PMID: 22462624
   PubMed Web of Science ®Google Scholar
• Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178:1748 - 58; PMID: 17237424
   PubMed Web of Science ®Google Scholar
• Xie H, Tang SY, Luo XH, Huang J, Cui RR, Yuan LQ, Zhou HD, Wu XP, Liao EY. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007; 80:201 - 10; http://dx.doi.org/10.1007/s00223-006-0155-7; PMID: 17340225
   PubMed Web of Science ®Google Scholar
• Arner P. Visfatin--a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91:28 - 30; http://dx.doi.org/10.1210/jc.2005-2391; PMID: 16401830
   PubMed Web of Science ®Google Scholar
• Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, Stumvoll M, Fasshauer M. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005; 185:R1 - 8; http://dx.doi.org/10.1677/joe.1.06211; PMID: 15930160
   PubMed Web of Science ®Google Scholar
• MacLaren R, Cui W, Cianflone K. Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 2007; 9:490 - 7; http://dx.doi.org/10.1111/j.1463-1326.2006.00625.x; PMID: 17587391
   PubMed Web of Science ®Google Scholar
• Lv Q, Wang Y, Wang W, Wang L, Zhou X. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats. Endocr Res 2009; 34:130 - 41; http://dx.doi.org/10.3109/07435800903287061; PMID: 19878073
   PubMed Web of Science ®Google Scholar
• Mayi TH, Duhem C, Copin C, Bouhlel MA, Rigamonti E, Pattou F, Staels B, Chinetti-Gbaguidi G. Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages. FEBS J 2010; 277:3308 - 20; http://dx.doi.org/10.1111/j.1742-4658.2010.07729.x; PMID: 20608974
   PubMed Web of Science ®Google Scholar
• Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 2003; 63:7436 - 42; PMID: 14612543
   PubMed Web of Science ®Google Scholar
• Li L, Yang G, Shi S, Yang M, Liu H, Boden G. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009; 45:12 - 9; http://dx.doi.org/10.1016/j.cyto.2008.10.006; PMID: 19026557
   PubMed Web of Science ®Google Scholar
• Chang YC, Chang TJ, Lee WJ, Chuang LM. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Metabolism 2010; 59:93 - 9; http://dx.doi.org/10.1016/j.metabol.2009.07.011; PMID: 19765775
   PubMed Web of Science ®Google Scholar
• Varma V, Yao-Borengasser A, Rasouli N, Bodles AM, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, McGehee RE Jr., et al. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J Clin Endocrinol Metab 2007; 92:666 - 72; http://dx.doi.org/10.1210/jc.2006-1303; PMID: 17090638
   PubMed Web of Science ®Google Scholar
• Curat CA, Wegner V, Sengenès C, Miranville A, Tonus C, Busse R, Bouloumié A. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49:744 - 7; http://dx.doi.org/10.1007/s00125-006-0173-z; PMID: 16496121
   PubMed Web of Science ®Google Scholar
• Garten A, Petzold S, Barnikol-Oettler A, Körner A, Thasler WE, Kratzsch J, Kiess W, Gebhardt R. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem Biophys Res Commun 2010; 391:376 - 81; http://dx.doi.org/10.1016/j.bbrc.2009.11.066; PMID: 19912992
   PubMed Web of Science ®Google Scholar
• Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14:1431 - 7; PMID: 8289818
   PubMed Web of Science ®Google Scholar
• Song HK, Lee MH, Kim BK, Park YG, Ko GJ, Kang YS, Han JY, Han SY, Han KH, Kim HK, et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 2008; 295:F1485 - 94; http://dx.doi.org/10.1152/ajprenal.90231.2008; PMID: 18768589
   PubMed Web of Science ®Google Scholar
• Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, Galli M, Leo O, So A, De Smedt T. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 2008; 3:e2267; http://dx.doi.org/10.1371/journal.pone.0002267; PMID: 18493620
   PubMed Web of Science ®Google Scholar
• Wanecq E, Prévot D, Carpéné C. Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes. J Physiol Biochem 2009; 65:351 - 9; http://dx.doi.org/10.1007/BF03185930; PMID: 20358348
   PubMed Web of Science ®Google Scholar
• Skop V, Kontrova K, Zidek V, Sajdok J, Pravenec M, Kazdova L, Mikulik K, Zidkova J. Autocrine effects of visfatin on hepatocyte sensitivity to insulin action. Physiol Res 2010; 59:615 - 8; PMID: 19929131
   PubMed Web of Science ®Google Scholar
• Kang YS, Song HK, Lee MH, Ko GJ, Han JY, Han SY, Han KH, Kim HK, Cha DR. Visfatin is upregulated in type-2 diabetic rats and targets renal cells. Kidney Int 2010; 78:170 - 81; http://dx.doi.org/10.1038/ki.2010.98; PMID: 20375985
   PubMed Web of Science ®Google Scholar
• Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007; 115:972 - 80; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.665893; PMID: 17283255
   PubMed Web of Science ®Google Scholar
• Gouranton E, Yazidi CE, Cardinault N, Amiot MJ, Borel P, Landrier JF. Purified low-density lipoprotein and bovine serum albumin efficiency to internalise lycopene into adipocytes. Food Chem Toxicol 2008; 46:3832 - 6; http://dx.doi.org/10.1016/j.fct.2008.10.006; PMID: 18957315
   PubMed Web of Science ®Google Scholar
• Landrier JF, Gouranton E, El Yazidi C, Malezet C, Balaguer P, Borel P, Amiot MJ. Adiponectin expression is induced by vitamin E via a peroxisome proliferator-activated receptor gamma-dependent mechanism. Endocrinology 2009; 150:5318 - 25; http://dx.doi.org/10.1210/en.2009-0506; PMID: 19833717
   PubMed Web of Science ®Google Scholar
• Landrier JF, Malezet-Desmoulins C, Reboul E, Marie Lorec A, Josephe Amiot M, Borel P. Comparison of different vehicles to study the effect of tocopherols on gene expression in intestinal cells. Free Radic Res 2008; 42:523 - 30; http://dx.doi.org/10.1080/10715760802098859; PMID: 18484416
   PubMed Web of Science ®Google Scholar
• Hassan M, El Yazidi C, Landrier JF, Lairon D, Margotat A, Amiot MJ. Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochem Biophys Res Commun 2007; 361:208 - 13; http://dx.doi.org/10.1016/j.bbrc.2007.07.021; PMID: 17658475
   PubMed Web of Science ®Google Scholar
• Landrier JF, Gouranton E, Reboul E, Cardinault N, El Yazidi C, Malezet-Desmoulins C, André M, Nowicki M, Souidi M, Borel P. Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells. J Nutr Biochem 2010; 21:1207 - 13; http://dx.doi.org/10.1016/j.jnutbio.2009.10.008; PMID: 20149624
   PubMed Web of Science ®Google Scholar
• Gouranton E, Thabuis C, Riollet C, Malezet-Desmoulins C, El Yazidi C, Amiot MJ, Borel P, Landrier JF. Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem 2011; 22:642 - 8; http://dx.doi.org/10.1016/j.jnutbio.2010.04.016; PMID: 20952175
   PubMed Web of Science ®Google Scholar
• Marcotorchino J, Gouranton E, Romier B, Tourniaire F, Astier J, Malezet C, Amiot MJ, Landrier JF. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 2012; 56:1771 - 82; http://dx.doi.org/10.1002/mnfr.201200383; PMID: 23065818
   PubMed Web of Science ®Google Scholar